# An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment

> **NCT01466673** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Ltd.,Thailand** · enrollment: 201 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Ethinyl estradiol/Norgestimate (EE/NGM)
- **DRUG:** Ethinyl estradiol/Desogestrel (EE/DSG)

## Key facts

- **NCT ID:** NCT01466673
- **Lead sponsor:** Janssen-Cilag Ltd.,Thailand
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466673, "An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01466673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*